Studies have shown that downregulation of VSTM2A protein and VSTM2A DNA promoter hypermethylation is associated with poor survival of CRC patients and hyperactivation of the Wnt/β-catenin signaling pathway is a critical step in colorectal tumorigenesis. The gene discussed is VSTM2A; the disease is colorectal carcinoma.